Tooru (TOO)  reported a strong first half of 2026, with its operating businesses generating more than £1 million of EBITDA as growth in OAF and a recovery at Pulsin supported performance.

Net revenue for the six months to 30 June rose to £5.21 million, from £1.01 million a year earlier, while EBITDA increased to £564,000 from £32,000. Cash stood at £1.45 million at the period end, compared with £1.03 million a year earlier.

On a comparable basis across the underlying businesses, total EBITDA reached £1.06 million, against £783,000 in the first half of 2025. Juvela generated £809,000 of EBITDA, while Pulsin and We Love Purely contributed £154,000 and Market Rocket £99,000.

OAF was the standout growth driver, delivering more than 100% year-on-year sales growth in the first six months. Distribution expanded across major retailers, with increased listings at Tesco and new Asda listings from April. The group said the momentum gives it confidence in OAF's prospects for the remainder of the year and beyond.

Juvela continued to perform strongly in retail OAF sales, while its prescription business remained broadly stable, although slightly below the comparative period.

Pulsin experienced a slower first quarter because of supply chain issues but has since returned to growth. The business is benefiting from significant cost savings following its move to outsourced production, while a new Swiss distribution agreement is expected to support its development.

The group also raised £980,000 during the period and converted £300,000 of debt.

After the period end, Tooru sold Market Rocket, a move it said would allow it to focus more closely on managing and developing its leading consumer brands in the wellness sector.

Chairman Nicholas Lee said the group was optimistic that the progress made in the first half would continue into the second half of 2026, while chief executive Scott Livingston said the combination of OAF growth, stability in Juvela's prescription business and renewed momentum at Pulsin demonstrated progress across the portfolio.

View from Vox

Tooru enters the second half with its portfolio looking more focused. OAF's rapid growth is the clearest positive, while Pulsin's recovery and lower production costs add another potential growth lever. The sale of Market Rocket should also sharpen management's focus on the group's consumer brands.